Hyocholic Acid structure
|
Common Name | Hyocholic Acid | ||
---|---|---|---|---|
CAS Number | 547-75-1 | Molecular Weight | 408.571 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 565.7±40.0 °C at 760 mmHg | |
Molecular Formula | C24H40O5 | Melting Point | 188-189ºC | |
MSDS | N/A | Flash Point | 310.0±23.8 °C |
Use of Hyocholic AcidHyocholic Acid is a bile acid found in pig. Hyocholic Acid can also be found in urine samples from patients with cholestasis. Hyocholic Acid promotes GLP-1 secretion via activating TGR5 and inhibiting FXR in enteroendocrine cells. Hyocholic Acid is known for its exceptional resistance to type 2 diabetes [1][2][3]. |
Name | hyocholic acid |
---|---|
Synonym | More Synonyms |
Description | Hyocholic Acid is a bile acid found in pig. Hyocholic Acid can also be found in urine samples from patients with cholestasis. Hyocholic Acid promotes GLP-1 secretion via activating TGR5 and inhibiting FXR in enteroendocrine cells. Hyocholic Acid is known for its exceptional resistance to type 2 diabetes [1][2][3]. |
---|---|
Related Catalog | |
In Vitro | HCA (25 and 50 μM, 24 h) upregulates GLP-1 protein secretion in STC-1 and NCI-H716 cells[3]. HCA (25 and 50 μM, 24 h) upregulates proglucagon gene transcription in STC-1 and NCI-H716 cells[3]. Western Blot Analysis[3] Cell Line: NCI-H716 cells Concentration: 50 μM Incubation Time: 48 h Result: Inhibited the high expression of SHP (small heterodimer partner) induced by the FXR agonist. |
In Vivo | Hyocholic Acid (20 mg/kg, p.o.) suppresses BA depletion-induced blood glucose increase in pigs[3]. Hyocholic Acid (100 mg/kg/day, p.o.) improves serum fasting GLP-1 secretion and glucose homeostasis in diabetic mouse models[3]. Animal Model: BA depletion pigs[3] Dosage: 20 mg/kg Administration: Oral administration (p.o.) Result: Attenuated the increased blood glucose levels corresponding with GLP-1 decrease. Animal Model: db/db model, and the high-fat diet and streptozotocin (HFD+STZ) induced diabetic model[3] Dosage: 100 mg/kg/day Administration: Oral administration (p.o.) Result: Improved oral glucose tolerances shown by lower glucose levels. Increased circulating active GLP-1 levels and fasting insulin levels. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 565.7±40.0 °C at 760 mmHg |
Melting Point | 188-189ºC |
Molecular Formula | C24H40O5 |
Molecular Weight | 408.571 |
Flash Point | 310.0±23.8 °C |
Exact Mass | 408.287567 |
PSA | 97.99000 |
LogP | 3.82 |
Vapour Pressure | 0.0±3.5 mmHg at 25°C |
Index of Refraction | 1.558 |
Precursor 7 | |
---|---|
DownStream 4 | |
3Alpha,6Alpha,7Alpha-Trihydroxy-5Beta-cholanic Acid |
Hyocholic Acid |
Cholan-24-oic acid, 3,6,7-trihydroxy-, (3α,5β,6α,7α)- |
(3α,5β,6α,7α)-3,6,7-Trihydroxycholan-24-oic acid |
3a,6a,7a-Trihydroxy-5b-cholan-24-oic acid |